Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice

    loading  Checking for direct PDF access through Ovid

Abstract

Mice of the C57BL/6 strain are resistant to the development of skin squamous carcinomas (SCCs) induced by an activated Ras oncogene, whereas FVB/N mice are highly susceptible1. The genetic basis of this difference in phenotype is unknown. Here we show that susceptibility to SCC is under the control of a carboxy-terminal polymorphism in the mousePtchgene. F1hybrids between C57BL/6 and FVB/N strains ((B6FVB)F1) are resistant to Ras-induced SCCs, but resistance can be overcome either by elimination of the C57BL/6Ptchallele (PtchB6) or by overexpression of the FVB/NPtchallele (PtchFVB) in the epidermis ofK5Hras-transgenic (B6FVB)F1hybrid mice. The humanPatched(PTCH) gene is a classical tumour suppressor gene for basal cell carcinomas and medulloblastomas, the loss of which causes increased signalling through theSonic Hedgehog(SHH) pathway2-5. SCCs that develop inPtchB6+/−mice do not lose the wild-typePtchgene or show evidence of increased SHH signalling. AlthoughPtchFVBoverexpression can promote SCC formation, continued expression is not required for tumour maintenance, suggesting a role at an early stage of tumour cell lineage commitment. ThePtchpolymorphism affects Hras-induced apoptosis, and binding to Tid1, the mouse homologue of theDrosophila l(2)tidtumour suppressor gene. We propose thatPtchoccupies a critical niche in determining basal or squamous cell lineage, and that both tumour types can arise from the same target cell depending on carcinogen exposure and host genetic background.

Related Topics

    loading  Loading Related Articles